Whitepapers/App Notes/Posters

Application note: Robust by design – how BD is overcoming the biologics challenge in drug delivery

Posted: 25 August 2020 | | No comments yet

This application note explores how BD is dedicated to deliver best-in-class product performance and services by applying the latest advances in drug delivery technology.

Becton, Dickinson and Company (BD) is developing a 2.25mL dose volume fully integrated autoinjector with BD Neopak XtraFlow – BD’s latest pre-fillable glass-based syringe system featuring an 8mm needle with ultra-thin wall cannula technology. BD has designed autoinjectors that can deliver drugs of differing viscosities in a well-integrated robust system. Pharmaceutical companies can adapt BD Intevia to deliver a range of drug volumes and viscosities without any need for customisation of the system or its components.











To read this application note in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


*

*

*

*

*

*

*

*

This content is provided to you for free thanks to the kind support of our sponsors: Becton Dickinson

Related organisations

Send this to a friend